Tag:#Novel Food

EFSA’s Request For Human CBD Toxicology Data Is ‘Unusual’ For a Food Authority

Susanne Caspar CEO of Swiss botanical extraction company Linnea SA analyses Europe’s latest CBD deliberations. WE were not surprised by the European Food Safety Authority’s (EFSA) decision...

EFSA ‘Stopping The Clock’ On EU CBD Novel Foods Applications, But Doubts Remain Over Decision’s Impact In UK

THE European Food Safety Authority (EFSA) issued a statement last week announcing that its scientists ‘cannot currently establish the safety of cannabidiol (CBD) as...

One Year Late The FSA Publishes List Of Eligible UK CBD Products – For Now

AFTER a delay of exactly one year the long-awaited Public List of validated UK CBD products has been published by the Food Standards Agency. This...

CBD Industry’s Anger At ‘Unprofessional Approach’ Of Regulators To Novel Food Process 

AS Brains Bioceutical becomes the latest company to make it on to the Public List of Validated Novel Food CBD applicants, sections of the...

A Ground-Breaking Year For European Cannabis Mapped Out In BusinessCann’s 2021 Top 10

THIS has been a remarkable year for European cannabis with some significant milestones passed on an increasingly fruitful trek into the post-prohibition era. Top of...

Germany Needs Workable Adult-Use Legislation Capable Of Drying-Up The Illicit Market.

Leading German Cannabis Lawyer Kai-Friedrich Niermann reflects on 2021 and looks ahead to the challenges and opportunities that lie ahead in 2022 BC: What are...

CBD Consumers Want Trusted Brands And High-Quality Products Backed By Regulators and Retailers

In a Q&A with BusinessCann Eoin Keenan, CEO & Co-Founder, Goodrays, says after seven years working in the industry he expects 2022 to be...

New THC Level Guidance Welcomed – But Further Concerns UK CBD Industry Is To Become Isolates Only

MUCH-AWAITED guidance on the permitted levels of THC in UK CBD products has been met with a mixed response and sparked some concerns over...

Latest news

European Cannabis Stocks Review: Love Hemp Announces ‘Cessation’ Of LSE Listing Process, More From Cellular Goods & Stenocare

Love Hemp Love Hemp, which has had its shares suspended from trading on the Aquis Stock Exchange (AQSE) since May...
- Advertisement -spot_imgspot_img

European Round-Up: Successful Cannabis Debut For Chemical Multinational, Germany Addresses Hurdles To Reform, French Medical Cannabis Twist, Maltese Hold-Ups et al…

CONCERNS the creation of an adult-use cannabis market will contravene international law have been dismissed by senior members of...

Glass Pharms Announces Partners In UK Cultivation Facility: KUBO To Build State-Of-The-Art Greenhouse 

HAVING secured up to £26.7m of funding from a FTSE-250 listed investment fund, Glass Pharms, the UK-based medical cannabis...

Must read